Skip to content

The Effect of Lansoprazole Orally Disintegrating Combine Rebanipide and Lansoprazole Orally Disintegrating on Ulcer after Endoscopic Submucosal Dissection: A Randomized,Double Blind,Controlled,Multi-center Clinical Trail.

The Effect of Lansoprazole Orally Disintegrating Combine Rebanipide and Lansoprazole Orally Disintegrating on Ulcer after Endoscopic Submucosal Dissection: A Randomized,Double Blind,Controlled,Multi-center Clinical Trail.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003032
Enrollment
Unknown
Registered
2013-01-22
Start date
2013-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcer after Endoscopic Submucosal Dissection

Interventions

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years old or 18 years old and over; 2. Normal blood coagulation; 3. Meet the ESD indications; 4. Able and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who have previous hemorrhage of upper digestive tract; 2. Patients who have other serious diseases; 3. Uncontrolled serious diseases of heart, liver, lung, renal and so on; 4. Patients who have used drugs inhibition acid or mucosal protective agents; 5. Patients who have to use other drugs; 6. Patients who had attend other clinical trails; 7. Allergy to pantoprazolelansoprazole or rebamipide; 8. Pregnant or lactating women; 9. Alcoholism or drug addiction patients; 10. Serious complications after ESD, such as bleeding or infection.

Design outcomes

Primary

MeasureTime frame
healing rate of ulcer;VEGF;EGF;PGE2;COX-2;IL-6, IL-8;

Countries

China

Contacts

Public ContactYang Yunsheng
sunny301ddc@126.com+86 010-55499005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026